Risk factors for TB in Australia and their association with delayed treatment completion
Author(s) -
N. J. Coorey,
L. Kensitt,
J. Davies,
E. Keller,
Meru Sheel,
Kudakwashe Chani,
Simone Barry,
Roslyn N. Boyd,
Justin T. Denholm,
Krista Watts,
Greg J. Fox,
Christopher Lowbridge,
Rebecca Perera,
Justin Waring,
Ben J. Marais,
Kerri Viney
Publication year - 2022
Publication title -
the international journal of tuberculosis and lung disease
Language(s) - English
Resource type - Journals
eISSN - 1815-7920
pISSN - 1027-3719
DOI - 10.5588/ijtld.21.0111
Subject(s) - medicine , logistic regression , incidence (geometry) , prospective cohort study , multivariate analysis , tuberculosis , cohort study , cohort , diabetes mellitus , physics , pathology , optics , endocrinology
BACKGROUND: Australia has a low incidence of TB and has committed to eliminating the disease. Identification of risk factors associated with TB is critical to achieving this goal. METHODS: We undertook a prospective cohort study involving persons receiving TB treatment in four Australian jurisdictions. Risk factors and their association with delayed treatment completion (treatment delayed by at least 1 month) were analysed using univariate analyses and multivariate logistic regression. RESULTS: Baseline surveys were completed for 402 persons with TB. Most (86.1%) were born overseas. Exposure to a person with TB was reported by 19.4%. Diabetes mellitus (10.2%), homelessness (9.2%), cigarette smoking (8.7%), excess alcohol consumption (6.0%) and mental illness (6.2%) were other common risk factors. At follow-up, 24.8% of patients had delayed treatment completion, which was associated with adverse events (34.1%, aOR 6.67, 95% CI 3.36-13.27), excess alcohol consumption (6.0%, aOR 21.94, 95% CI 6.03-79.85) and HIV co-infection (2.7%, aOR 8.10, 95% CI 1.16-56.60). CONCLUSIONS: We identified risk factors for TB and their association with delayed treatment completion, not all of which are routinely collected for surveillance purposes. Recognition of these risk factors should facilitate patient-centred care and assist Australia in reaching TB elimination.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom